Central effects of the somatotropic system
Year: 2003
Type: article
Abstract: The somatotropic axis interacts with the central nervous system (CNS) on several levels. Growth hormone (GH) and insulin-like growth factor-I (IGF-I) receptors are expressed in many brain areas including the hippocampus, pituitary and hypothalamus. GH and IGF-I can pass the blood-brain barrier by an as yet not completely understood mechanism. They can also be produced in the brain and thus act via paracrine/autocrine mechanisms. GH and IGF-I are important factors in the development and differentiation of the CNS and have protective properties in dementia, and in traumatic and ischemic injury of the CNS. An improvement in cognitive functioning in GH-deficient patients by GH substitution has been shown. Significant results could, however, only be achieved with supraphysiological doses. In some studies, a correlation between IGF-I and cognitive function in the elderly has been found. GH has an important impact on mood and well-being with GH secretory capacity being reduced in depression. Pulsatile GH secretion is closely related to slow wave sleep (SWS) with SWS being stimulated by GH releasing hormone and rapid eye movement (REM) sleep by GH.
Authors: HJ Schneider, U Pagotto, GK Stalla
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: somatotropic axis, growth hormone, insulin-like growth factor I, central nervous system, blood-brain barrier, autocrine and paracrine signaling, neuroprotection, dementia, traumatic brain injury, ischemic brain injury, GH deficiency, growth hormone therapy, cognitive function, depression, slow-wave sleep, REM sleep, hypothalamus
Open Access status: green
OpenAlex ID: W2169266124
